Back to search
Brain Tumors and/or Solid Tumors Including
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Brain Tumors and/or Solid Tumors Including trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Brain Tumors and/or Solid Tumors Including trials you may qualify forThis phase I/II trial evaluates the best dose, side effects and possible benefit of CBL0137 in treating patients with solid tumors, including central nervous sy…
Glioblastoma (GBM) is the most common and lethal primary brain tumor. Identifying blood biomarkers that reflect the tumor's status is a major unmet need for opt…
The purpose of this study is to test the usefulness of imaging with radiolabeled methionine in the evaluation of children and young adults with tumor(s). Methio…
This phase I trial studies the side effects and best dose of selinexor in treating younger patients with solid tumors or central nervous system (CNS) tumors tha…
This is a Phase I clinical trial evaluating abemaciclib (LY2835219), an inhibitor of cyclin dependent-kinases 4 and 6 (Cdk 4/6) in children and young adults wit…